The company makes software that can be used on iPhones, iPads or desktop computers to assess cognitive decline and screen for diseases like Alzheimer’s or other types of dementia. BrainCheck also secured strategic investment from UPMC Enterprises and SelectQuote.īrainCheck said the latest round of funding brings its total raise to $20 million. ![]() ![]() The round was led by Next Coast Ventures and S3 Ventures, with participation from Nueterra Capital, Tensility Ventures and True Wealth Ventures. BrainCheck, the company behind a platform that helps assess cognitive impairment, has raised $10 million in Series B funding.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |